AK

Anoop Kumar Tripathi

Active Director Managing Director DIN 11529584
DIN 11529584 First appointment Feb 2026 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Anoop Kumar Tripathi

Data last updated:

Anoop Kumar Tripathi is a Managing Director at Kailash Biosciences Private Limited (since 2026). The company operates in Biotechnology.

DIN 11529584
Primary Designation Managing Director
Industry Biotechnology
First Appointment 06 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kailash Biosciences Private Limited U46497UT2026PTC020795
Managing Director06 Feb 20262026Active

Board colleagues of Anoop Kumar Tripathi

NameDINCompanyDesignation
Jyoti Tripathi11529583Kailash Biosciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kailash Biosciences Private Limited
Premium access

Shareholding and investment profile for Anoop Kumar Tripathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anoop Kumar Tripathi

Anoop Kumar Tripathi currently holds 1 directorship: Kailash Biosciences Private Limited (Managing Director, since 06 Feb 2026).

Anoop Kumar Tripathi was first appointed on 06 Feb 2026 as Managing Director at Kailash Biosciences Private Limited.

The current boards of Anoop Kumar Tripathi's companies include Jyoti Tripathi (Kailash Biosciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available